Ventilator-Associated Pneumonia: New Definitions

M Chance Spalding, Michael W Cripps, Christian T Minshall, M Chance Spalding, Michael W Cripps, Christian T Minshall

Abstract

The National Healthcare Safety Network's new classification characterizes all adverse ventilator-associated events (VAE) into a tiered system designed to shift the focus away from ventilator-associated pneumonia as the only important cause or morbidity in ventilated patients. This new surveillance definition of VAE eliminates subjectivity by using clearly defined criteria and facilitates the automated collection of data. This allows for easier comparison and analysis of factors affecting rates of VAE. Numerous studies have been published that demonstrate its clinical application. This article presents the VAE criteria, contrasts the difference from the previous ventilator-associated pneumonia definition, and discusses its implementation over the past 5 years.

Keywords: Critical care; Nosocomial infection; Sepsis; Ventilator-associated pneumonia.

Copyright © 2016 Elsevier Inc. All rights reserved.

Figures

Fig. 1
Fig. 1
Targeting VAE. Broad description of ventilator-related complications is more narrowly defined by each tier of the new CDC definition: VAC, IVAC, possible- or probable-VAP. Fio2, fraction of inspired oxygen; PEEP, positive end-expiratory pressure.
Fig. 2
Fig. 2
Diagram summarizing cumulative number of patients that met VAC, iVAC, and both possible- and probable-VAP criteria from the published studies summarized in Table 2.

References

    1. Van Vught L.A., Klowenberg P.M., Spitoni C., for the MARS Consortium Incidence, risk factors, and attributable mortality of secondary infections in the intensive care unit after admission for sepsis. JAMA. 2016;315(14):1469–1479.
    1. Magill S.S., Klompas M., Balk R. Developing a new, national approach to surveillance for ventilator-associated events. Am J Crit Care. 2013;22(6):469–473.
    1. Klompas M., Khan Y., Kleinman K. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS One. 2011;6:e18062.
    1. Muscedere J., Sinuff T., Heyland D.K., on behalf of for the Canadian Critical Care Trials Group The clinical impact and preventability of ventilator-associated conditions in critically ill patients who are mechanically ventilated. Chest. 2013;144(5):1453–1460.
    1. Hayashi Y., Morisawa K., Klompas M. Towards improved surveillance: the impact of ventilator-associated complications (VAC) on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis. 2012;56(4):471–477.
    1. Klouwenberg P.M., van Mourik M.S., Ong D.S. Electronic implementation of a novel surveillance paradigm for ventilator-associated events: feasibility and validation. Am J Respir Crit Care Med. 2014;189(8):947–955.
    1. Klompas M., Kleinman K., Murphy M.V., for the CDC Prevention Epicenters Program Descriptive epidemiology and attributable morbidity of ventilator-associated events. Infect Control Hosp Epidemiol. 2014;35(5):502–510.
    1. Stevens J.P., Silva G., Gillis J. Automated surveillance for ventilator-associated events. Chest. 2014;146(6):1612–1618.
    1. Lilly C.M., Landry K.E., Sood R.N. Prevalence and test characteristics of national health safety network ventilator-associated events. Crit Care Med. 2014;42(9):2019–2028.
    1. Chang H.C., Chen C.M., Kung S.C. Differences between novel and conventional surveillance paradigms of ventilator-associated pneumonia. Am J Infect Control. 2015;43(2):133–136.
    1. Boyer A.F., Schoenberg N., Babcock H. A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. Chest. 2015;147(1):68–81.
    1. Boudma L., Sonneville R., Garrouste-Orgeas M. Ventilator-associated events: prevalence, outcome, and relationship with ventilator-associated pneumonia. Crit Care Med. 2015;43(9):1798–1806.
    1. Metersky M.L., Wang Y., Klompas M. Trend in ventilator-associated pneumonia rates between 2005 and 2013. JAMA. 2016;316(22):2427–2429.
    1. Stoeppel C.M., Eriksson E.A., Hawkins K. Applicability of the National Healthcare Safety Network’s surveillance definition of ventilator-associated events in the surgical intensive care unit: a 1-year review. J Trauma Acute Care Surg. 2014;77(6):934–937.
    1. McMullen K.M., Boyer A.F., Schoenberg N. Surveillance versus clinical adjudication: differences persist with new ventilator-associated event definition. Am J Infect Control. 2015;43(6):589–591.
    1. Klompas M., Anderson D., Trick W. The preventability of ventilator-associated events. The CDC prevention epicenters wake up and breathe collaborative. Am J Respir Crit Care Med. 2015;191(3):292–301.
    1. Lewis S.C., Li L., Murphy M.V. Risk factors for ventilator-associated events: a case-control multivariable analysis. Crit Care Med. 2014;42(8):1839–1848.
    1. Resetar E., McMullen K.M., Russo A.J. Development, implementation and use of electronic surveillance for ventilator-associated events (VAE) in adults. AMIA Annu Symp Proc. 2014;2014:1010–1017.
    1. Nuckchady D., Heckman M.G., Diehl N.N. Assessment of an automated surveillance system for detection of initial ventilator-associated events. Am J Infect Control. 2015;43(10):1119–1121.
    1. Zhu S., Cai L., Ma C. The clinical impact of ventilator-associated events: a prospective multi-center surveillance study. Infect Control Hosp Epidemiol. 2015;36(12):1388–1395.
    1. Prospero E., Illuminati D., Marigliano A. Learning from Galileo: ventilator-associated pneumonia surveillance. Am J Respir Crit Care Med. 2012;186(12):1308–1309.
    1. Dessap A.M., Katsahian S., Roche-Campo F. Ventilator-associated pneumonia during weaning from mechanical ventilation: role of fluid management. Chest. 2014;146(1):58–65.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe